Amaya Lujambio Goizueta, PhD
img_Amaya Lujambio Goizueta
ASSOCIATE PROFESSOR | Oncological Sciences
Research Topics
Cancer, Epigenetics, Liver, Molecular Biology
Multi-Disciplinary Training Area
Cancer Biology [CAB], Immunology [IMM]
Liver Cancer Biology
Amaia Lujambio´s research group studies mechanisms of liver cancer initiation and liver cancer maintenance. In particular, we are interested in how genetic alterations in cancer cells contribute to tumorigenesis, alter treatment response, and create vulnerabilities that may be targeted therapeutically. Furthermore, we are also interested in understanding the role of cellular senescence in liver cancer initiation. Our research interests involve the establishment of in vitro and in vivo systems for the study of liver cancer as well as the rational use of shRNA libraries to identify drug targets for the disease. We utilize sophisticated mouse models of cancer, RNAi technology, valuable human cancer samples, and genetic and epigenetic profiling as key tools. The ultimate goal is to improve our understanding of liver cancer biology and to identify novel strategies that can be exploited therapeutically.

Visit theLujambio Laboratory

PhD, Spanish National Cancer Center (CNIO)

Postdoc, Cold Spring Harbor Laboratory (CSHL)

Postdoc, Memorial Sloan Kettering Cancer Center


AASLD Pinnacle Research Award in Liver Diseases



EMBO Long Term Fellowship



Ph.D. Thesis Award

Universidad Autónoma de Madrid


EMBO Short Term Fellowship



Eduardo Gallego Award

Fundación Francisco Cobos


FPU Fellowship

Spanish Goverment

Cancer Precision Medicine Retreat -- Session 5: Amaia Lujambio

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Lujambio Goizueta during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.


  • National Cancer Institute (NCI)
  • Department of Defense (DoD)
  • agence nationale de la recherche
  • mineco
  • University of Pittsburgh
  • La Caixa
  • Memorial Sloan-Kettering Cancer Center (MSKCC)

Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose

  • University of Pennsylvania
  • Clinic barcelona
  • Young Investigator Live

Royalty Payments:

  • Algen

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.